These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12599581)

  • 1. [Genitourinary and rectal toxicity after radiation therapy for prostate cancer].
    Akimoto T; Saito J; Kitamoto Y
    Nihon Rinsho; 2002 Dec; 60 Suppl 11():255-60. PubMed ID: 12599581
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: use of dose-volume constraints to achieve rectal isotoxicity.
    Vargas C; Yan D; Kestin LL; Krauss D; Lockman DM; Brabbins DS; Martinez AA
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):141-9. PubMed ID: 16111582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bladder and rectal toxicity of BeamCath application in radiotherapy of prostate cancer.
    Hanssen S; Norum J
    Anticancer Res; 2008; 28(5B):2865-8. PubMed ID: 19031926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In regard to Fiorino et al.: Rectal dose-volume constraints in high-dose radiotherapy of localized prostate cancer (Int J Radiat Oncol Biol Phys 2003;57:953-962).
    Bauman G; Rodrigues G
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):912-4; author reply 914-5. PubMed ID: 15183497
    [No Abstract]   [Full Text] [Related]  

  • 5. [Dosimetric factors predictive of late toxicity in prostate cancer radiotherapy].
    de Crevoisier R; Fiorino C; Dubray B
    Cancer Radiother; 2010 Oct; 14(6-7):460-8. PubMed ID: 20797890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acute toxicity in 50 patients with prostate cancer treated with conformal radiation therapy].
    Nasr E; Merhej S; Nehme Nasr D; Fares G
    J Med Liban; 2001; 49(6):325-8. PubMed ID: 12744634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A method for the prediction of late organ-at-risk toxicity after radiotherapy of the prostate using equivalent uniform dose.
    Fleming C; Kelly C; Thirion P; Fitzpatrick K; Armstrong J
    Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):608-13. PubMed ID: 20934261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between acute and late toxicity in 973 prostate cancer patients treated with three-dimensional conformal external beam radiotherapy.
    Jereczek-Fossa BA; Zerini D; Fodor C; Santoro L; Serafini F; Cambria R; Vavassori A; Cattani F; Garibaldi C; Gherardi F; Ferrari A; Rocco B; Scardino E; de Cobelli O; Orecchia R
    Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):26-34. PubMed ID: 20133085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric impact and theoretical clinical benefits of fiducial markers for dose escalated prostate cancer radiation treatment.
    Gauthier I; Carrier JF; Béliveau-Nadeau D; Fortin B; Taussky D
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1128-33. PubMed ID: 19147306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastro-intestinal and genito-urinary morbidity after 3D conformal radiotherapy of prostate cancer: observations of a randomized trial.
    Koper PC; Jansen P; van Putten W; van Os M; Wijnmaalen AJ; Lebesque JV; Levendag PC
    Radiother Oncol; 2004 Oct; 73(1):1-9. PubMed ID: 15465140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fitting late rectal bleeding data using different NTCP models: results from an Italian multi-centric study (AIROPROS0101).
    Rancati T; Fiorino C; Gagliardi G; Cattaneo GM; Sanguineti G; Borca VC; Cozzarini C; Fellin G; Foppiano F; Girelli G; Menegotti L; Piazzolla A; Vavassori V; Valdagni R
    Radiother Oncol; 2004 Oct; 73(1):21-32. PubMed ID: 15465142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Searching for optimal dose-volume constraints to reduce rectal toxicity after hypofractionated radiotherapy for prostate cancer.
    Faria S; Joshua B; Patrocinio H; Dal Pra A; Cury F; Velly AM; Souhami L
    Clin Oncol (R Coll Radiol); 2010 Dec; 22(10):810-7. PubMed ID: 20980135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Volume and hormonal effects for acute side effects of rectum and bladder during conformal radiotherapy for prostate cancer.
    Peeters ST; Hoogeman MS; Heemsbergen WD; Slot A; Tabak H; Koper PC; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1142-52. PubMed ID: 15939547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of volume and location of irradiated rectum wall on rectal blood loss after radiotherapy of prostate cancer.
    Koper PC; Heemsbergen WD; Hoogeman MS; Jansen PP; Hart GA; Wijnmaalen AJ; van Os M; Boersma LJ; Lebesque JV; Levendag P
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1072-82. PubMed ID: 15001247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of mean rectal dose on late rectal bleeding after conformal radiotherapy for prostate cancer: dose-volume effect.
    Zapatero A; García-Vicente F; Modolell I; Alcántara P; Floriano A; Cruz-Conde A; Torres JJ; Pérez-Torrubia A
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1343-51. PubMed ID: 15275719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective three-dimensional analysis about the impact of differences in the clinical target volume in prostate cancer irradiation on normal-tissue exposure. A potential for increasing the benefit/risk ratio.
    Hille A; Töws N; Schmidberger H; Hess CF
    Strahlenther Onkol; 2005 Dec; 181(12):789-95. PubMed ID: 16362789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-grade toxicity after conformal radiation therapy for prostate cancer--impact of bladder volume.
    Pinkawa M; Fischedick K; Asadpour B; Gagel B; Piroth MD; Eble MJ
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):835-41. PubMed ID: 16289911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer.
    Zelefsky MJ; Levin EJ; Hunt M; Yamada Y; Shippy AM; Jackson A; Amols HI
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1124-9. PubMed ID: 18313526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late rectal and urinary toxicity from conformal, dose-escalated radiation therapy for prostate cancer: a prospective study of 402 patients.
    Lin C; Turner S; Mai T; Kneebone A; Gebski V
    Australas Radiol; 2007 Dec; 51(6):578-83. PubMed ID: 17958696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical toxicities and dosimetric parameters after whole-pelvis versus prostate-only intensity-modulated radiation therapy for prostate cancer.
    Deville C; Both S; Hwang WT; Tochner Z; Vapiwala N
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):763-72. PubMed ID: 20171807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.